PARP Inhibitor-Sensitized Radionuclide Therapy Combined With Immune Checkpoint Inhibitors: A Review of Mechanistic Synergy, Tumor Microenvironment Remodeling, and Systemic Immune Effects

Discovery Medicine · Published 2026-06-18 · DOI 10.24976/discov.med.202638209.132

Free full text

Authors (6)

Jinfeng Rong, Yan Xu, Hongjia Zhu, Xue Zhou, Yan Chen, Linquan Mu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Rong, J., Xu, Y., Zhu, H., et al. (2026). PARP Inhibitor-Sensitized Radionuclide Therapy Combined With Immune Checkpoint Inhibitors: A Review of Mechanistic Synergy, Tumor Microenvironment Remodeling, and Systemic Immune Effects. Discovery Medicine. https://doi.org/10.24976/discov.med.202638209.132

Related articles